Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

176 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of Nonantiretroviral Medications That May Impact Neurocognition: Patterns and Predictors in a Large, Long-Term HIV Cohort Study.
Radtke KK, Bacchetti P, Anastos K, Merenstein D, Crystal H, Karim R, Weber KM, Edmonds A, Sheth AN, Fischl MA, Vance D, Greenblatt RM, Rubin LH. Radtke KK, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2018 Jun 1;78(2):202-208. doi: 10.1097/QAI.0000000000001658. J Acquir Immune Defic Syndr. 2018. PMID: 29762344 Free PMC article.
Nonnucleoside reverse transcriptase inhibitor pharmacokinetics in a large unselected cohort of HIV-infected women.
Gandhi M, Benet LZ, Bacchetti P, Kalinowski A, Anastos K, Wolfe AR, Young M, Cohen M, Minkoff H, Gange SJ, Greenblatt RM; Women's Interagency HIV Study. Gandhi M, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):482-91. doi: 10.1097/qai.0b013e31819c3376. J Acquir Immune Defic Syndr. 2009. PMID: 19408353 Free PMC article.
Cognitive Burden of Common Non-antiretroviral Medications in HIV-Infected Women.
Rubin LH, Radtke KK, Eum S, Tamraz B, Kumanan KN, Springer G, Maki PM, Anastos K, Merenstein D, Karim R, Weber KM, Gustafson D, Greenblatt RM, Bishop JR. Rubin LH, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2018 Sep 1;79(1):83-91. doi: 10.1097/QAI.0000000000001755. J Acquir Immune Defic Syndr. 2018. PMID: 29781879 Free PMC article.
Prevalence and correlates of highly active antiretroviral therapy switching in the Women's Interagency HIV Study.
Kirstein LM, Greenblatt RM, Anastos K, Levine A, French AL, Minkoff H, Silver S, Gange SJ; Women's Interagency HIV Study Collaborative Research Group. Kirstein LM, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):495-503. doi: 10.1097/00126334-200204150-00010. J Acquir Immune Defic Syndr. 2002. PMID: 11981366
Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy.
Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, DeHovitz J, Delapenha R, Hoover DR. Anastos K, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):383-92. doi: 10.1097/00126334-200404010-00008. J Acquir Immune Defic Syndr. 2004. PMID: 15097155
Factors and temporal trends associated with highly active antiretroviral therapy discontinuation in the Women's Interagency HIV Study.
Ahdieh-Grant L, Tarwater PM, Schneider MF, Anastos K, Cohen M, Khalsa A, Minkoff H, Young M, Greenblatt RM; Women's Interagency HIV Study. Ahdieh-Grant L, et al. Among authors: greenblatt rm. J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):500-3. doi: 10.1097/01.qai.0000138160.91568.19. J Acquir Immune Defic Syndr. 2005. PMID: 15764968
176 results